Researchers create voluntary safety rules for AI protein design

March 9, 2024

Ai proteins

A group of leading scientists has launched a voluntary initiative outlining a set of values, principles, and commitments for AI protein design. 

The letter discusses the potential misuse of AI tools capable of designing new proteins with unprecedented speed and efficiency. 

While AI holds immense promise for addressing pressing global challenges, from pandemic response to sustainable energy solutions, it also raises questions about the possibility of malicious use, such as creating novel bioweapons.

While the proteins designed by DeepMind’s AlphaFold system and later by researchers at the University of Washington School of Medicine demonstrated high affinity and specificity to their intended targets, there is always the possibility that these proteins could interact with other molecules in the body in unexpected ways. 

This could lead to adverse side effects or even the development of new diseases.

Another risk is the potential for misuse or malicious use of this technology. Just as AI-designed proteins can be used to create highly targeted therapies, they could also be engineered to cause harm. 

For example, a malicious actor could potentially design a protein that targets a specific ethnic group or exploits a particular genetic vulnerability. 

As David Baker, a computational biophysicist at the University of Washington and a key figure behind the initiative, notes, “The question was: how, if in any way, should protein design be regulated and what, if any, are the dangers?”

The 100+ signatories believe that “the benefits of current AI technologies for protein design far outweigh the potential for harm” but recognize the need for a proactive approach to risk management as the technology advances. 

The letter states that “given anticipated advances in this field, a new proactive risk management approach may be required to mitigate the potential of developing AI technologies that could be misused, intentionally or otherwise, to cause harm.”

As part of the initiative, researchers articulated a set of values and principles to guide the responsible development of AI technologies in protein design.

These include “safety, security, equity, international collaboration, openness, responsibility, and pursuing research for the benefit of society.” The signatories have also voluntarily agreed to a set of specific, actionable commitments informed by these values and principles.

One key aspect of the initiative focuses on improving the screening of DNA synthesis, a crucial step in translating AI-designed proteins into physical molecules. 

The scientists commit to “obtain DNA synthesis services only from providers that demonstrate adherence to industry-standard biosecurity screening practices, which seek to detect hazardous biomolecules before they can be manufactured.”

AI’s advances in medicine and biotechnology have been quite incredible, leading to new antibiotics and anti-aging drugs.

To drive these findings forward, the signatories commit to “work collaboratively with stakeholders from around the world” and “refrain from research likely to lead to overall harm or enable misuse of our technologies.”

Join The Future


Clear, concise, comprehensive. Get a grip on AI developments with DailyAI

Sam Jeans

Sam is a science and technology writer who has worked in various AI startups. When he’s not writing, he can be found reading medical journals or digging through boxes of vinyl records.


Stay Ahead with DailyAI

Sign up for our weekly newsletter and receive exclusive access to DailyAI's Latest eBook: 'Mastering AI Tools: Your 2024 Guide to Enhanced Productivity'.

*By subscribing to our newsletter you accept our Privacy Policy and our Terms and Conditions